A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
Condition: Childhood Nephrotic Syndrome Interventions: Drug: Obinutuzumab; Drug: MMF; Drug: Prednisone; Drug: Methylprednisolone; Drug: Acetaminophen/ Paracetamol; Drug: Diphenhydramine Hydrochloride Sponsor: Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acetaminophen | Lortab | Methylprednisolone | Nephrotic Syndrome | Prednisone | Research | Study